Back to Companies who have applied for FDA Drug Approval

FDA Drug Approval Applications Sponsored by MERCK SHARP DOHME

Application NumberDrugs/ProductsApplication TypeMost Recent Label Available FlagCurrent Patent FlagAction TypeChemical TypeTher PotentialOrphan Code
001546 New Drug Application Approval
014215 New Drug Application Approval New formulation (S) Standard review drug
014602 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
016096 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
016097 New Drug Application Approval New formulation (S) Standard review drug
017555 New Drug Application Approval New molecular entity (NME); New combination (P) Priority review drug
018741 New Drug Application Approval New formulation (S) Standard review drug
018827 New Drug Application Approval New combination (S) Standard review drug
019543 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
019555 New Drug Application Approval New formulation (S) Standard review drug
019625 New Drug Application Approval New formulation (S) Standard review drug
019716 New Drug Application Approval New formulation (S) Standard review drug
019796 New Drug Application Approval New formulation (S) Standard review drug
019856 New Drug Application Approval New formulation (S) Standard review drug
020010 New Drug Application Approval New formulation; New combination (S) Standard review drug
020145 New Drug Application Approval
020249 New Drug Application Approval New formulation (S) Standard review drug
020386 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
020387 New Drug Application Approval New combination (S) Standard review drug
020685 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
020762 New Drug Application Approval New formulation (S) Standard review drug
020903 New Drug Application Approval New formulation (P) Priority review drug
021029 New Drug Application Approval New molecular entity (NME) (P) Priority review drug (V) Orphan drug
021067 New Drug Application Approval New formulation (S) Standard review drug
021165 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
021300 New Drug Application Approval New formulation (S) Standard review drug
021312 New Drug Application Approval New formulation (S) Standard review drug
021313 New Drug Application Approval New manufacturer (S) Standard review drug
021337 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
021605 New Drug Application Approval New formulation (S) Standard review drug
021995 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
022044 New Drug Application Approval New combination (S) Standard review drug
022145 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
022277 New Drug Application Approval New formulation (S) Standard review drug
022518 New Drug Application Approval New combination (S) Standard review drug
050742 New Drug Application Approval New molecular entity (NME)
125514 Biologic License Application Approval
200153 New Drug Application Approval New combination (S) Standard review drug
202258 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
202270 New Drug Application Approval New formulation (S) Standard review drug
202343 New Drug Application Approval New combination (S) Standard review drug
203045 New Drug Application Approval New formulation (P) Priority review drug
204569 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
205053 New Drug Application Approval New formulation (S) Standard review drug
205596 New Drug Application Approval New formulation (P) Priority review drug
205641 New Drug Application Approval New ester, new salt, or other noncovalent derivative (S) Standard review drug
205786 New Drug Application Approval New formulation (P) Priority review drug
206510 New Drug Application Approval New combination (S) Standard review drug
208261 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
761046 Biologic License Application Approval

Back to Companies who have applied for FDA Drug Approval


 

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.